Toward Patient-Centered Drug Development in On... - CLL Support

CLL Support

22,370 members38,481 posts

Toward Patient-Centered Drug Development in Oncology

Cllcanada profile image
CllcanadaTop Poster CURE Hero
1 Reply

Not CLL specific but interesting...from the NEJM

Quote...

'As an oncologist, when I sit with patients to discuss starting a new chemotherapy regimen, their first questions are often “How will it make me feel?” and “How did patients like me feel with this treatment?” Regrettably, this information is generally missing from U.S. drug labels and from published reports of clinical trials — the two information sources most commonly available to people trying to understand the clinical effects of cancer drugs.'

....

Cancer-drug labels stand in sharp contrast to labels for other types of drugs, about 25% of which list the drugs' effects on patients' symptoms or functioning.1 That disparity is surprising, given how common symptoms and functional impairment are in patients with cancer and how toxic oncology drugs can be.

End Quote...

nejm.org/doi/full/10.1056/N...

Written by
Cllcanada profile image
Cllcanada
Top Poster CURE Hero
To view profiles and participate in discussions please or .
Read more about...
1 Reply
Cllcanada profile image
CllcanadaTop Poster CURE Hero

Here is an addition article on this topic from Medscape...

medscape.com/viewarticle/80...

You may also like...

Ibrutinib denied to new patients

Learned today that the cancer drugs fund has removed Ibrutinib from its approved drugs list. Feels...

Making drug development less secretive could lead to quicker, cheaper therapies

investment, an open source drug discovery system – based on sharing all information in the public...

CAR-T coming to OSU Medical Center

was told by a patient that she was informed that she could be enrolled in a CAR-T Clinical Trial...

Specialty Treatment Center vs local oncologist

also consult either with Mayo, Cleveland Clinic or The James Cancer Center in Columbus. I live...

NHS decision takes away Ibrutinib from patients

https://www.thetimes.co.uk/edition/news/cancer-patients-denied-effective-drug-to-cut-costs-zv30zrk2k